Work Here?
Overview
Celcuity develops targeted cancer therapies and companion diagnostics for solid tumors. Its CELsignia platform is a functional cellular analysis tool that identifies cancer subtypes and predicts how well a patient will respond to a given targeted treatment. Treatments and diagnostics are developed together to guide oncologists in prescribing drugs to patients most likely to benefit, starting with Gedatolisib for breast cancer. The company differentiates itself by using functional cellular analysis to personalize therapy selection rather than relying solely on traditional genetic information, aiming to improve treatment outcomes. Celcuity’s overarching goal is to advance personalized medicine in oncology by matching therapies with the right patients through its integrated drug and diagnostic programs.
About Celcuity
Industries
Biotechnology
Healthcare
Company Size
201-500
Company Stage
IPO
Headquarters
Minneapolis, Minnesota
Founded
2012
People at Celcuity
People at Celcuity who can refer or advise you
Simplify's Take
What believers are saying
- FDA Priority Review for wild-type indication with PDUFA date July 17, 2026 unlocks $5B market.
- Phase 3 VIKTORIA-1 showed 76% risk reduction and 9.3-month median PFS in wild-type patients.
- $484.3M net proceeds from convertible notes extend cash runway through 2027 for commercialization.
What critics are saying
- FDA rejection likely due to insufficient OFS gain despite positive PFS data, Prob 35–50% in 1–2 months.
- Commercial uptake may fail from IV adherence issues and oral PI3K competition, Prob 40–60% in 3–6 months.
- Approval limited to mutant-only patients negates pan-PI3K advantage, Prob 25–40% in 1–2 months.
What makes Celcuity unique
- Gedatolisib is the first PAM pathway inhibitor approved for PIK3CA wild-type breast cancer.
- Pan-PI3K/mTORC1/2 mechanism blocks PAM pathway comprehensively, enabling broader efficacy than single-target inhibitors.
- CELSignia platform uses functional cellular analysis to identify cancer subtypes and predict therapy effectiveness.
Help us improve and share your feedback! Did you find this helpful?
Funding
Total Funding
$1.6B
Above
Industry Average
Funded Over
14 Rounds
Benefits
Health Insurance
Dental Insurance
Vision Insurance
401(k) Company Match
Paid Vacation
Paid Holidays
Performance Bonus
Company Equity
Stock Price
Growth & Insights
6 month growth
↓ -9%1 year growth
↓ -10%2 year growth
↓ -7%Celcuity is Hiring for 2 Jobs on Simplify!
Find jobs on Simplify and start your career today
About Celcuity
Industries
Biotechnology
Healthcare
Company Size
201-500
Company Stage
IPO
Headquarters
Minneapolis, Minnesota
Founded
2012
Celcuity is Hiring for 2 Jobs on Simplify!
Find jobs on Simplify and start your career today